glp-1 dementia study Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and in Diabetes Mellitus Comparative dementia risk with GLP1

They are not recommended during breast-feeding

Compared with GLP-1 therapies, amylin mimetics could lead improve the quality of weight reduction, resulting in lower loss of lean mass relative to fat, according to the Leerink analysts

1986 Sep;7(9):1463-6

Astra is not affiliated with AstraZeneca, Astra Pharma, or any other company using a similar name.

The mice with hyper-long telomeres exhibited reduced DNA damage with aging, improved metabolic markers such as lower LDL levels, improved glucose and insulin tolerance, decreased cancer incidence, and increased longevity (Muoz-Lorente et al., 2019)

13 It is estimated that the economic burden of COPD in the next 20 years will increase by $40 billion per year